China 139-85-5 Factory

We have now probably the most innovative production equipment, experienced and qualified engineers and workers, regarded high quality control systems and also a friendly expert income team pre/after-sales support for 139-85-5,CAS NO 139-85-5,Erlotinib intermediate,Erlotinib advance intermediate,Protocatechualdehyde, For even more inquires make sure you will not wait to make contact with us. Thank you - Your help continuously inspires us.
139-85-5, Our company adheres to the spirit of "lower costs, higher quality, and making more benefits for our clients". Employing talents from the same line and adhering to the principle of "honesty, good faith, real thing and sincerity", our company hopes to gain common development with clients from both at home and abroad!

Hot Products

  • 3-[(1S)-1-(Dimethylaminoethyl)]phenol

    3-[(1S)-1-(Dimethylaminoethyl)]phenol

    Product Name:3-[(1S)-1-(Dimethylaminoethyl)]phenol
    Molecular Formula:C10H15NO
    Molecular Weight:165.23
    CAS Registry Number:139306-10-8
  • Eplerenone

    Eplerenone

    Product Name:Eplerenone
    Molecular Formula:C24H30O6
    Molecular Weight:414.49
    CAS Registry Number;107724-20-9
  • 3-Fluorobenzyl bromide

    3-Fluorobenzyl bromide

    Product Name:3-Fluorobenzyl bromide
    Molecular Formula:C7H6BrF
    Molecular Weight:189.02
    CAS Registry Number:456-41-7
  • Trityl losartan

    Trityl losartan

    Product Name:Trityl losartan
    Molecular Formula:C41H37ClN6O
    Molecular Weight:665.23
    CAS Registry Number:133909-99-6
  • Coenzyme Q10

    Coenzyme Q10

    Product Name:Coenzyme Q10 Molecular Formula:C59H90O4
    Molecular Weight:863.36
    CAS Registry Number:303-98-0
    EINECS:206-147-9
  • Tetrabutylammonium hydroxide

    Tetrabutylammonium hydroxide

    Product Name:Tetrabutylammonium hydroxide
    Molecular Formula:C16H37NO
    Molecular Weight:259.47
    CAS Registry Number:2052-49-5

Send Inquiry

X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept